Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Total Current Liabilities (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Total Current Liabilities for 17 consecutive years, with $11.8 million as the latest value for Q1 2026.

  • Quarterly Total Current Liabilities rose 65.96% to $11.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Mar 2026, up 65.96% year-over-year, with the annual reading at $9.1 million for FY2025, 35.92% up from the prior year.
  • Total Current Liabilities for Q1 2026 was $11.8 million at Achieve Life Sciences, up from $9.1 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $21.6 million in Q4 2022, with the low at $3.4 million in Q2 2023.
  • Average Total Current Liabilities over 5 years is $10.6 million, with a median of $8.6 million recorded in 2025.
  • The sharpest move saw Total Current Liabilities soared 406.26% in 2023, then tumbled 67.9% in 2024.
  • Achieve Life Sciences' Total Current Liabilities stood at $21.6 million in 2022, then fell by 3.64% to $20.8 million in 2023, then tumbled by 67.9% to $6.7 million in 2024, then surged by 35.92% to $9.1 million in 2025, then surged by 30.29% to $11.8 million in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Total Current Liabilities are $11.8 million (Q1 2026), $9.1 million (Q4 2025), and $9.7 million (Q3 2025).